Pharma companies oppose vociferously 45 days' time period given to them for replacing existing stocks

Taking their cue from Cipla and Alembic, many in the pharmaceutical industry have challenged the new drug price fixation orders that were to be implemented from July 29. The move is expected to delay the introduction of low-priced medicines in the market.